| Glioma targeted therapy: insight into future of molecular approaches K Yang, Z Wu, H Zhang, N Zhang, W Wu, Z Wang, Z Dai, X Zhang, ... Molecular Cancer 21 (1), 39, 2022 | 344 | 2022 |
| Regulatory mechanisms of immune checkpoints PD-L1 and CTLA-4 in cancer H Zhang, Z Dai, W Wu, Z Wang, N Zhang, L Zhang, WJ Zeng, Z Liu, ... Journal of Experimental & Clinical Cancer Research 40 (1), 184, 2021 | 255 | 2021 |
| Immune checkpoint modulators in cancer immunotherapy: recent advances and emerging concepts Y Wang, H Zhang, C Liu, Z Wang, W Wu, N Zhang, L Zhang, J Hu, P Luo, ... Journal of Hematology & Oncology 15 (1), 111, 2022 | 123 | 2022 |
| Glioblastoma treatment modalities besides surgery H Zhang, R Wang, Y Yu, J Liu, T Luo, F Fan Journal of Cancer 10 (20), 4793, 2019 | 112 | 2019 |
| The molecular feature of macrophages in tumor immune microenvironment of glioma patients H Zhang, YB Luo, W Wu, L Zhang, Z Wang, Z Dai, S Feng, H Cao, ... Computational and structural biotechnology journal 19, 4603-4618, 2021 | 87 | 2021 |
| Engineering better chimeric antigen receptor T cells H Zhang, P Zhao, H Huang Experimental hematology & oncology 9, 1-13, 2020 | 85 | 2020 |
| The adaptive transition of glioblastoma stem cells and its implications on treatments Z Wang, H Zhang, S Xu, Z Liu, Q Cheng Signal transduction and targeted therapy 6 (1), 124, 2021 | 65 | 2021 |
| Novel insights into astrocyte-mediated signaling of proliferation, invasion and tumor immune microenvironment in glioblastoma H Zhang, Y Zhou, B Cui, Z Liu, H Shen Biomedicine & Pharmacotherapy 126, 110086, 2020 | 65 | 2020 |
| Machine learning-based identification of tumor-infiltrating immune cell-associated lncRNAs for improving outcomes and immunotherapy responses in patients with low-grade glioma N Zhang, H Zhang, W Wu, R Zhou, S Li, Z Wang, Z Dai, L Zhang, F Liu, ... Theranostics 12 (13), 5931, 2022 | 64 | 2022 |
| Patient-derived xenograft models in cancer therapy: technologies and applications Y Liu, W Wu, C Cai, H Zhang, H Shen, Y Han Signal Transduction and Targeted Therapy 8 (1), 160, 2023 | 63 | 2023 |
| PDIA4: The basic characteristics, functions and its potential connection with cancer Z Wang, H Zhang, Q Cheng Biomedicine & Pharmacotherapy 122, 109688, 2020 | 63 | 2020 |
| Circadian clock genes promote glioma progression by affecting tumour immune infiltration and tumour cell proliferation Z Wang, G Su, Z Dai, M Meng, H Zhang, F Fan, Z Liu, L Zhang, N Weygant, ... Cell proliferation 54 (3), e12988, 2021 | 58 | 2021 |
| Machine learning-based tumor-infiltrating immune cell-associated lncRNAs for predicting prognosis and immunotherapy response in patients with glioblastoma H Zhang, N Zhang, W Wu, R Zhou, S Li, Z Wang, Z Dai, L Zhang, Z Liu, ... Briefings in bioinformatics 23 (6), bbac386, 2022 | 55 | 2022 |
| B2M overexpression correlates with malignancy and immune signatures in human gliomas H Zhang, B Cui, Y Zhou, X Wang, W Wu, Z Wang, Z Dai, Q Cheng, K Yang Scientific Reports 11 (1), 5045, 2021 | 49 | 2021 |
| Immune infiltrating cells-derived risk signature based on large-scale analysis defines immune landscape and predicts immunotherapy responses in glioma tumor microenvironment N Zhang, H Zhang, Z Wang, Z Dai, X Zhang, Q Cheng, Z Liu Frontiers in Immunology 12, 691811, 2021 | 40 | 2021 |
| The predictive value of monocytes in immune microenvironment and prognosis of glioma patients based on machine learning N Zhang, Z Dai, W Wu, Z Wang, H Cao, Y Zhang, Z Wang, H Zhang, ... Frontiers in Immunology 12, 656541, 2021 | 37 | 2021 |
| PDIA5 is correlated with immune infiltration and predicts poor prognosis in gliomas H Zhang, J He, Z Dai, Z Wang, X Liang, F He, Z Xia, S Feng, H Cao, ... Frontiers in Immunology 12, 628966, 2021 | 37 | 2021 |
| PDIA3 correlates with clinical malignant features and immune signature in human gliomas H Zhang, Y Zhou, Q Cheng, Z Dai, Z Wang, F Liu, F Fan, B Cui, H Cao Aging (Albany NY) 12 (15), 15392, 2020 | 34 | 2020 |
| Novel immune infiltrating cell signature based on cell pair algorithm is a prognostic marker in cancer H Zhang, Z Wang, Z Dai, W Wu, H Cao, S Li, N Zhang, Q Cheng Frontiers in immunology 12, 694490, 2021 | 29 | 2021 |
| Tumor buster-where will the CAR-T cell therapy ‘missile’go? C Qu, H Zhang, H Cao, L Tang, H Mo, F Liu, L Zhang, Z Yi, L Long, L Yan, ... Molecular Cancer 21 (1), 201, 2022 | 28 | 2022 |
